SARS-CoV-2 Task Force

SARS-CoV-2 Task Force

About The Task Force

With representatives from 32 GVN CoEs in 13 countries, the GVN SARS-CoV-2 Task Force meets virtually bimonthly to monthly to share latest research findings and to discuss diagnostics, serological tests and vaccine development.

Task Force Members

  • Larry Blatt (GVN, USA)
  • Christian Brechot (GVN, USA)
  • Franco Buonaguro (Instituto Tumori, Italy)
  • Mike Catton (Doherty/VIDRL, Australia)
  • Konstantin Chumakov (FDA/OVRR, USA)
  • Christian Drosten (Charite U of Berlin, Germany)
  • Julian Druce (Doherty/Melbourne Hospital, Australia)
  • Heinz Ellerbrok (Robert Koch Institute, Germany)
  • Rebecca Elliott (Doherty Institute, Australia)
  • Matthew Frieman (University of Maryland School of Medicine, USA)
  • Robert Gallo (IHV Maryland, USA)
  • Robert Garry (Tulane, USA)
  • Howard Gendelman (University of Nebraska Medical Center, USA)
  • Elodie Ghedin (NYU Global Public Health, USA)
  • Dale Godfrey (University of Melbourne, Australia)
  • Tony Goldberg (University of Wisconsin, USA)
  • Birendra Gupta (Nepal (independent), Nepal)
  • William Hall (University College Dublin, Ireland)
  • “Giuseppe Ippolito (National Institute for
  • Infectious Diseases Lazzaro Spallanzani, Italy)”
  • Alexander Khromykh (University of Queensland (AIDRC), Australia)
  • Marion Koopmans (Erasmus MC, Netherlands)
  • Shyam Kottilil (IHV Maryland, USA)
  • Florian Krammer (Icahn School of Medicine at Mount Sinai, USA)
  • Chris Kratochvil (University of Nebraska Medical Center, USA)
  • Benhur Lee (Icahn School of Medicine at Mount Sinai, USA)
  • Sharon Lewin (Doherty Institute, Australia
  • Natalia Majo (IRTA-CRESA, Spain)
  • Roscoe Moore (GVN, USA)
  • Gene Morse (University at Buffalo, USA)
  • Mihai Netea (Radboud University, Netherlands)
  • Johan Neyts (KU Leuven, Belgium)
  • Ab Osterhaus (TiHo Hannover, Germany)
  • David Ostrov (University of Florida, USA)
  • Peter Palese (Icahn School of Medicine at Mount Sinai, USA)
  • Damian Purcell (Doherty Institute, Australia)
  • Igor Puzanov (Roswell Park Cancer Institute, USA)
  • Pardis Sabeti (Broad Institute, USA)
  • Amadou Sall (Institut Pasteur Senegal, Senegal)
  • Erica Ollmann Saphire (La Jolla Institute, USA)
  • Syed Sattar (University of Ottawa, Canada)
  • Richard Scheuermann (J. Craig Venter Institute, USA)
  • Ray Schinazi (GVN Board/Emory University, USA)
  • Joaquim Segales (IRTA-CRESA, Spain)
  • Yiming Shao (China CDC, China)
  • Robert Silverman (Lerner Research Institute – Cleveland Clinic, USA)
  • Christine Stabell Stabell Benn (Southern Denmark University, Denmark)
  • Andreas Suhrbier (QIMR Berghofer (AIDRC), Australia)
  • David Topham (University of Rochester, USA)
  • Linfa Wang (NUS-Duke, USA)
  • Scott Weaver (University of Texas Medical Branch, USA)
  • Paul Young (University of Queensland (AIDRC), Australia)